Project Grant R43EY023505

This $745,607 Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of the RETIVUE ENTIREEYE, a handheld, high-resolution, non-contact, single-image, widefield retinal screening camera for premature and healthy newborn babies. The device utilizes a novel all-digital, no moving parts scanning light module to capture a seamless, high-quality, diagnostic ultra-widefield image of the entire baby eye in a single shot. This technology has the...

This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $306,462 to Ifocus Imaging LLC to develop a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy using optical coherence tomography angiography (OCTA) imaging and artificial intelligence. The key products to be delivered under this award include: 1) Improved AI-based segmentation of OCTA image...

This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop and validate a novel Adaptive Optics Optical Coherence Tomography (AO-OCT) system tailored for high-resolution, wide-field retinal imaging in small animal models, specifically mice. The $305,000 project, awarded on September 1, 2025, with an expected completion date of August 31, 2026, has two key objectives: Develop and optimize a portable AO-OCT system with enhanced imaging capabilities...

The National Eye Institute (NEI) awarded a $256,296 Project Grant (CFDA 93.867 - Vision Research) to The General Hospital Corporation (Massachusetts General Hospital) to develop new "Auto-Sensing, Instantaneous Adaptive Ranging Optical Coherence Tomography (OCTA)" technology. This technology aims to expand the imaging depth range of OCTA systems, enabling improved visualization of the critical peripheral retinal microvasculature. The project will leverage advances in integrated...

The National Eye Institute (NEI) awarded a Project Grant of $305,853 to Bluebird Photonics, Inc. under the Vision Research federal grant program (CFDA 93.867) to develop a novel light source for robust multi-MHz retinal optical coherence tomography (OCT). The project aims to enable next-generation OCT technology that can provide diagnostic screening and visualization of both the central and peripheral retinal areas through a roughly 50-fold increase in imaging speed. This advancement is...

This NIH Research Infrastructure Programs (CFDA 93.351) award to Baylor College of Medicine provides $1,386,474 to acquire a Femtonics ATLAS microscope, a cutting-edge two-photon microscope that enables rapid, high-resolution 3D imaging of neuronal activity using calcium, voltage, and neurotransmitter indicators. The ATLAS microscope will support a diverse set of NIH-funded neuroscience projects at Baylor College of Medicine, allowing researchers to track activity in complex 3D neural structures...

This Project Grant award from the National Eye Institute's Vision Research program (CFDA 93.867) provides funding of $179,440 to Kennesaw State University to develop an innovative smartphone-based retinal imaging system and deep learning algorithms for detecting diabetic retinopathy in Egypt. The two-phase project aims to create a portable and cost-effective retinal imaging solution that can enhance access to screening for this serious diabetes complication, which can lead to vision loss without...

This is a Cooperative Agreement award from the National Eye Institute (NEI), part of the U.S. Department of Health and Human Services, under the Vision Research federal grant program (CFDA 93.867). The $791,994 award, which began on September 1, 2025, supports the development of a next-generation ophthalmic microscope with integrated optical coherence tomography (OCT) imaging capabilities. The project aims to overcome limitations of current ophthalmic surgery microscopes by enabling more...

The National Eye Institute (NEI) awarded a $673,747 Project Grant to New York University (NYU) for the "Visible-to-Near-Infrared Spanning Optical Coherence Tomography for Retinal Imaging at the Half-Micron Scale" research project under the NEI's Vision Research program (CFDA 93.867). The grant aims to develop advanced optical coherence tomography (OCT) techniques to enable more accurate in vivo measurement and localization of macular pigments and retinal pigment epithelium melanosomes,...

The National Eye Institute (NEI) awarded a $295,766 Project Grant (CFDA 93.867 - Vision Research) to Ther-Ai LLC, located in Oviedo, FL, to develop a smartphone application called ILIGN. The goal of this project is to create a rapid, non-invasive, and accurate artificial intelligence-driven system to pre-screen for ocular misalignment (strabismus), a leading cause of preventable blindness in children. The expected outcome is a software platform that allows untrained end-users to diagnose...